Giovanni Ughi to Everolimus
This is a "connection" page, showing publications Giovanni Ughi has written about Everolimus.
Connection Strength
0.476
-
Teeuwen K, Spoormans EM, Bennett J, Dubois C, Desmet W, Ughi GJ, Belmans A, Kelder JC, Tijssen JGP, Agostoni P, Suttorp MJ, Adriaenssens T. Optical coherence tomography findings: insights from the "randomised multicentre trial investigating angiographic outcomes of hybrid sirolimus-eluting stents with biodegradable polymer compared with everolimus-eluting stents with durable polymer in chronic total occlusions" (PRISON IV) trial. EuroIntervention. 2017 Aug 04; 13(5):e522-e530.
Score: 0.139
-
Dubois C, Bennett J, Dens J, De Cock D, Desmet W, Belmans A, Ughi GJ, Sinnaeve P, Vrolix M, D'hooge J, Adriaenssens T. COmplex coronary Bifurcation lesions: RAndomized comparison of a strategy using a dedicated self-expanding biolimus-eluting stent versus a culotte strategy using everolimus-eluting stents: primary results of the COBRA trial. EuroIntervention. 2016 Apr 20; 11(13):1457-67.
Score: 0.127
-
Ughi GJ, Dubois C, Desmet W, D'hooge J, Adriaenssens T. Provisional side branch stenting: presentation of an automated method allowing online 3D OCT guidance. Eur Heart J Cardiovasc Imaging. 2013 Jul; 14(7):715.
Score: 0.102
-
Adriaenssens T, Ughi GJ, Dubois C, De Cock D, Onsea K, Bennett J, Wiyono S, Sinnaeve P, Coosemans M, Ferdinande B, Belmans A, D'hooge J, Desmet W. STACCATO (Assessment of Stent sTrut Apposition and Coverage in Coronary ArTeries with Optical coherence tomography in patients with STEMI, NSTEMI and stable/unstable angina undergoing everolimus vs. biolimus A9-eluting stent implantation): a randomised controlled trial. EuroIntervention. 2016 Apr 08; 11(14):e1619-26.
Score: 0.032
-
Adriaenssens T, Dens J, Ughi G, Bennett J, Dubois C, Sinnaeve P, Wiyono S, Coosemans M, Belmans A, D'hooge J, Vrolix M, Desmet W. Optical coherence tomography study of healing characteristics of paclitaxel-eluting balloons vs. everolimus-eluting stents for in-stent restenosis: the SEDUCE (Safety and Efficacy of a Drug elUting balloon in Coronary artery rEstenosis) randomised clinical trial. EuroIntervention. 2014 Aug; 10(4):439-48.
Score: 0.028
-
Dubois C, Adriaenssens T, Ughi G, Wiyono S, Bennett J, Coosemans M, Ferdinande B, Sinnaeve P, D'hooge J, Desmet W. Healing responses after bifurcation stenting with the dedicated TRYTON Side-Branch Stent? in combination with XIENCE-V? stents: a clinical, angiography, fractional flow reserve, and optical coherence tomography study: the PYTON (Prospective evaluation of the TRYTON Side-Branch Stent? with an additional XIENCE-v? everolimus-eluting stent in coronary bifurcation lesions) study. Catheter Cardiovasc Interv. 2013 Feb; 81(3):E155-64.
Score: 0.025
-
Adriaenssens T, Dens J, Ughi G, Coosemans M, Onsea K, Dubois C, Sinnaeve P, Vrolix M, Desmet W. Optical coherence tomography (OCT) in PCI for in-stent restenosis (ISR): rationale and design of the SEDUCE (Safety and Efficacy of a Drug elUting balloon in Coronary artery rEstenosis) study. EuroIntervention. 2011 May; 7 Suppl K:K100-5.
Score: 0.023